Consumo não-Cíclico
ABEV3 — AMBEV S.A.
CNPJ 07.526.557/0001-00 · listed classes: ABEV3 · CVM code 23264
The full history, year by year
The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.
| indicator | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE ⟶ | 22.3%! | 28.4% | 27.4% | 26.9% | 16.1% | 21.5% | 20.0% | 16.8% | 16.2% | 17.6% | 18.0% | 16.3% | 16.6% |
| ROIC ⟶ | 35.8%! | 38.3% | 38.6% | 39.8% | 23.7% | 33.1% | 29.6% | 24.1% | 24.9% | 25.2%! | 26.7% | 23.6% | 26.6% |
| ROA ⟶ | 16.5%! | 17.6% | 15.9% | 15.0% | 9.2% | 12.6% | 12.4% | 10.3% | 9.9% | 10.8% | 11.1% | 10.1% | 10.4% |
| Gross margin ⟶ | 67.2% | 66.3% | 65.6% | 63.4% | 62.3% | 61.6% | 58.8% | 53.6% | 51.1% | 49.3% | 50.7% | 51.2% | 51.4% |
| EBIT margin ⟶ | 44.2% | 41.6% | 40.2% | 37.5% | 34.3% | 33.8% | 30.5% | 27.3% | 23.3% | 22.2% | 23.4% | 24.4% | 26.5% |
| Net margin ⟶ | 32.6% | 32.5% | 27.6% | 28.7% | 16.4% | 22.7% | 23.2% | 20.1% | 18.0% | 18.7% | 18.8% | 16.6% | 18.1% |
| Revenue growth (1y) ⟶ | — | 8.6% | 22.7% | -2.4% | 5.0% | 4.9% | 4.7% | 12.3% | 24.8% | 9.4% | 0.0% | 12.2% | -1.4% |
| Revenue growth (5y CAGR) ⟶ | — | — | — | — | — | 7.4% | 6.7% | 4.6% | 9.8% | 10.7% | 9.7% | 11.5% | 8.6% |
| Net debt/EBITDA ⟶ | -0.50x | -0.43x | -0.47x | -0.13x | -0.39x | -0.43x | -0.43x | -0.66x | -0.69x | -0.49x | -0.51x | -0.91x | -0.56x |
| Current ratio ⟶ | 1.19x | 0.95x | 0.94x | 0.83x | 0.86x | 1.02x | 1.10x | 1.06x | 0.99x | 0.93x | 0.89x | 1.10x | 0.96x |
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue | profit | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2024T1! | 20,276.3 | 3,804.2 | 18.8% | 13.2 | 2.21 | 2024-05-08 |
| 2024T2! | 20,044.2 | 2,451.9 | 12.2% | 12.8 | 1.94 | 2024-08-01 |
| 2024T3! | 22,096.7 | 3,566.3 | 16.1% | 14.3 | 2.03 | 2024-10-31 |
| 2025T1! | 22,497.4 | 3,804.6 | 16.9% | 15.6 | 2.38 | 2025-05-08 |
| 2025T2! | 20,090.2 | 2,790.6 | 13.9% | 13.2 | 2.10 | 2025-07-31 |
| 2025T3! | 20,847.3 | 4,863.7 | 23.3% | 12.2 | 2.13 | 2025-10-30 |
| 2026T1! | 22,464.5 | 3,885.6 | 17.3% | 16.7 | 2.88 | 2026-05-05 |
| 2026T2! | 20,148.9 | 3,474.7 | 17.2% | 15.2 | 2.79 | 2026-07-30 |
Full series, every quarter: GET /empresas/ABEV3/trimestres
Dividends per year
No dividends recorded. Note this can mean two different things — the company pays none, or we could not confirm. sem_proventos
Piotroski F-Score 6/9 (2025) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2012 | BPP 2.03 | 977.2 | 25,206.6 |
| 2012 | DMPL 5.07 | 977.2 | 25,206.6 |
| 2012 | BPA 1 | 1,346.3 | 25,236.9 |
| 2012 | BPP 2 | 1,346.3 | 25,236.9 |
| 2012 | DMPL 5.03 | 800.2 | 23,088.1 |
| 2012 | DMPL 5.05 | 226.2 | 6,641.6 |
| 2012 | DMPL 5.05.01 | 46.5 | 6,327.3 |
| 2012 | DRE 3.05 | 31.5 | 6,312.4 |
This company appears in
Other companies in Consumer Defensive
26 more with a page, same CVM sector — a classification of the regulator's, not ours.
Take this into your code
GET /empresas/ABEV3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 3,179 sessions, 2013-11-11 → 2026-09-04 · methodology · how we verify
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 10:37 UTC. If this does not match /saude, you are reading a cached copy.